These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 11100088)

  • 41. [Varicella--why vaccinate?].
    Heldenberg D
    Harefuah; 1995 Apr; 128(8):520-3. PubMed ID: 7750858
    [No Abstract]   [Full Text] [Related]  

  • 42. Varicella vaccination of immunocompromised children.
    Levin MJ
    J Infect Dis; 2008 Mar; 197 Suppl 2():S200-6. PubMed ID: 18419398
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful vaccination against varicella zoster virus prior to kidney transplantation.
    Geel A; Zuidema W; van Gelder T; van Doornum G; Weimar W
    Transplant Proc; 2005 Mar; 37(2):952-3. PubMed ID: 15848586
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of statistical models for evaluating antibody response as a correlate of protection against varicella.
    Chan IS; Li S; Matthews H; Chan C; Vessey R; Sadoff J; Heyse J
    Stat Med; 2002 Nov; 21(22):3411-30. PubMed ID: 12407681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Large injection site reactions after a second dose of varicella vaccine.
    Walter EB; Snyder MA; Clements DA; Katz SL
    Pediatr Infect Dis J; 2008 Aug; 27(8):757-9. PubMed ID: 18574438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
    Ampofo K; Saiman L; LaRussa P; Steinberg S; Annunziato P; Gershon A
    Clin Infect Dis; 2002 Mar; 34(6):774-9. PubMed ID: 11830801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaccination against varicella: what's the point?
    Gershon AA
    Adv Exp Med Biol; 2010; 659():83-7. PubMed ID: 20204757
    [No Abstract]   [Full Text] [Related]  

  • 48. [Trial of a varicella vaccine in 100 high-risk children].
    Vialatte J; Broyer M; Griscelli C; Gaiffe M; Badillet M; Georges AM
    Dev Biol Stand; 1982; 52():385-90. PubMed ID: 6299848
    [No Abstract]   [Full Text] [Related]  

  • 49. Perspective on live varicella vaccine.
    Gershon AA; Katz SL
    J Infect Dis; 2008 Mar; 197 Suppl 2():S242-5. PubMed ID: 18419404
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
    Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
    Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Varicella vaccine update: need for a booster?
    Hoey J
    CMAJ; 2003 Mar; 168(5):589. PubMed ID: 12615756
    [No Abstract]   [Full Text] [Related]  

  • 52. Evidence for frequent reactivation of the Oka varicella vaccine strain in healthy vaccinees.
    Krause PR
    Arch Virol Suppl; 2001; (17):7-15. PubMed ID: 11339552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of postexposure immunization with live attenuated varicella vaccine in the household setting--a pilot study.
    Mor M; Harel L; Kahan E; Amir J
    Vaccine; 2004 Dec; 23(3):325-8. PubMed ID: 15530676
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T; Baer M; Willems P
    Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Varicella vaccine.
    Gershon AA
    Isr J Med Sci; 1994; 30(5-6):482-4. PubMed ID: 8034507
    [No Abstract]   [Full Text] [Related]  

  • 56. Varlirix (GlaxoSmithKline).
    Arvin AM
    Curr Opin Investig Drugs; 2002 Jul; 3(7):996-9. PubMed ID: 12186278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Varicella vaccine in renal failure.
    Buttery JP; Moxon ER
    Lancet; 2000 Jun; 355(9219):1930. PubMed ID: 10859036
    [No Abstract]   [Full Text] [Related]  

  • 58. Live attenuated vaccine for the prevention of varicella-zoster virus infection: does it work, is it safe and do we really need it in the UK?
    Breuer J
    J Med Microbiol; 2003 Jan; 52(Pt 1):1-3. PubMed ID: 12488559
    [No Abstract]   [Full Text] [Related]  

  • 59. Varicella vaccine: genesis, efficacy, and attenuation.
    Arvin AM
    Virology; 2001 Jun; 284(2):153-8. PubMed ID: 11384215
    [No Abstract]   [Full Text] [Related]  

  • 60. Childhood vaccination against varicella: persistence of antibody, duration of protection, and vaccine efficacy.
    Vessey SJ; Chan CY; Kuter BJ; Kaplan KM; Waters M; Kutzler DP; Carfagno PA; Sadoff JC; Heyse JF; Matthews H; Li S; Chan IS
    J Pediatr; 2001 Aug; 139(2):297-304. PubMed ID: 11487760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.